Long non-coding RNA NORAD suppresses erastin-induced ferroptosis in breast cancer by upregulating SLC7A11 via

Pengfei Shi1, Bo Hu1, Yongjun Liu1

  • 1Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Abstract

Insights

Non-coding RNA activated by DNA damage (NORAD) suppresses ferroptosis in breast cancer (BC) by upregulating SLC7A11. This finding reveals NORAD as a potential therapeutic target for BC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Ferroptosis, a form of iron-dependent cell death, is a known impediment to various cancers, including breast cancer (BC).
  • High expression of non-coding RNA activated by DNA damage (NORAD) correlates with poor prognosis in BC patients.
  • The specific role of NORAD in BC ferroptosis remains largely unexplored.

Purpose of the Study:

  • To investigate the role of NORAD in regulating ferroptosis in breast cancer cells.
  • To elucidate the molecular mechanism by which NORAD influences ferroptosis.
  • To assess the in vivo effect of NORAD on breast cancer ferroptosis.

Main Methods:

  • Breast cancer cells were treated with erastin to induce ferroptosis.
  • Western blotting and qPCR assessed molecular levels; CCK-8 assays evaluated cell viability.
  • Mechanisms were explored using ChIP, luciferase reporter, and RIP assays; in vivo studies utilized a xenograft mouse model.

Main Results:

  • NORAD was highly expressed in human BC tissues and cells.
  • NORAD overexpression inhibited erastin-induced ferroptosis, while silencing facilitated it.
  • NORAD upregulated NR3C1 via FUS interaction, which in turn upregulated SLC7A11, reversing ferroptosis promotion by NORAD silencing.

Conclusions:

  • NORAD suppresses erastin-induced ferroptosis in breast cancer cells.
  • This suppression occurs through the FUS/NR3C1 axis, leading to the upregulation of SLC7A11.
  • NORAD's role in ferroptosis suppression suggests it as a potential therapeutic target for breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K